应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01672 歌礼制药-B
已收盘 05-08 16:08:16
6.670
+0.340
+5.37%
最高
6.740
最低
6.330
成交量
331.60万
今开
6.330
昨收
6.330
日振幅
6.48%
总市值
64.30亿
流通市值
64.30亿
总股本
9.64亿
成交额
2,181万
换手率
0.34%
流通股本
9.64亿
市净率
3.05
ROE
-13.97%
每股收益
-0.32
52周最高
9.280
52周最低
0.760
市盈率
-20.68
股息
0.00
股息收益率
0.00
ROA
-10.96%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
歌礼制药-B:股价涨 3.32% 减肥药催化
和讯网 · 04:42
歌礼制药-B:股价涨 3.32% 减肥药催化
歌礼制药-B股价上涨超3% 将公布肥胖症药物早期研究结果
DoNews · 04:06
歌礼制药-B股价上涨超3% 将公布肥胖症药物早期研究结果
港股异动 | 歌礼制药-B(01672)涨超3% 将公布肥胖症候选药物ASC47早期研究结果
智通财经 · 03:30
港股异动 | 歌礼制药-B(01672)涨超3% 将公布肥胖症候选药物ASC47早期研究结果
港股概念追踪|传闻世卫组织计划将减肥药纳入基本目录 减肥药研发进展加速(附概念股)
智通财经 · 05-07 07:04
港股概念追踪|传闻世卫组织计划将减肥药纳入基本目录 减肥药研发进展加速(附概念股)
歌礼制药-B盘中异动 下午盘股价大跌5.02%
市场透视 · 05-07 05:54
歌礼制药-B盘中异动 下午盘股价大跌5.02%
金十数据整理:每日港股市场要闻速递(5月7日 周三)
美港电讯 · 05-07 01:12
金十数据整理:每日港股市场要闻速递(5月7日 周三)
智通港股早知道 | 央行等部门将介绍一揽子金融政策支持稳市场稳预期 港交所推出“科企专线”
智通财经 · 05-06 23:18
智通港股早知道 | 央行等部门将介绍一揽子金融政策支持稳市场稳预期 港交所推出“科企专线”
歌礼宣布将在第32届欧洲肥胖症大会以口头和壁报形式报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果
美通社 · 05-06 08:55
歌礼宣布将在第32届欧洲肥胖症大会以口头和壁报形式报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果
歌礼制药(01672)将在第32届欧洲肥胖症大会上报告ASC47早期研究成果
金吾财讯 · 05-06 08:51
歌礼制药(01672)将在第32届欧洲肥胖症大会上报告ASC47早期研究成果
歌礼制药:欧洲肥胖症大会报告ASC47研究成果
美港电讯 · 05-06 08:43
歌礼制药:欧洲肥胖症大会报告ASC47研究成果
歌礼制药-B(01672)将在第32届欧洲肥胖症大会报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果
智通财经 · 05-06 08:42
歌礼制药-B(01672)将在第32届欧洲肥胖症大会报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果
歌礼制药-B盘中异动 快速上涨5.04%
市场透视 · 05-06 02:10
歌礼制药-B盘中异动 快速上涨5.04%
歌礼制药-B(01672)因购股权获行使合计发行4.7万股
智通财经 · 04-30
歌礼制药-B(01672)因购股权获行使合计发行4.7万股
歌礼制药-B04月30日主力净流出28.5万元 散户资金买入
市场透视 · 04-30
歌礼制药-B04月30日主力净流出28.5万元 散户资金买入
【港股收评:恒生指数涨0.51%,恒生科技指数涨1.35%】港股收盘,恒生指数涨0.51%,恒生科技指数涨1.35%。港股科技ETF(159751)收盘上涨1.44%,恒生港股通ETF(159318)收盘上涨0.58%。美图公司涨超10%,周大福涨超8%。老铺黄金跌超5%,歌礼制药-B跌超4%。
金融界 · 04-30
【港股收评:恒生指数涨0.51%,恒生科技指数涨1.35%】港股收盘,恒生指数涨0.51%,恒生科技指数涨1.35%。港股科技ETF(159751)收盘上涨1.44%,恒生港股通ETF(159318)收盘上涨0.58%。美图公司涨超10%,周大福涨超8%。老铺黄金跌超5%,歌礼制药-B跌超4%。
歌礼制药-B(01672)4月29日根据获采纳购股权计划发行合共18.75万股
智通财经 · 04-29
歌礼制药-B(01672)4月29日根据获采纳购股权计划发行合共18.75万股
歌礼制药-B盘中异动 下午盘股价大涨5.02%
市场透视 · 04-29
歌礼制药-B盘中异动 下午盘股价大涨5.02%
歌礼制药-B根据购股权计划发行17.2万股
智通财经 · 04-28
歌礼制药-B根据购股权计划发行17.2万股
歌礼制药-B(01672)根据购股权计划发行17.2万股
智通财经 · 04-28
歌礼制药-B(01672)根据购股权计划发行17.2万股
加入GLP-1混战,“中国本土丙肝药一哥”换赛道,歌礼制药欲靠减肥药翻身
时代财经 · 04-28
加入GLP-1混战,“中国本土丙肝药一哥”换赛道,歌礼制药欲靠减肥药翻身
加载更多
公司概况
公司名称:
歌礼制药-B
所属市场:
SEHK
上市日期:
2018-08-01
主营业务:
歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎(NASH)或原发性胆汁性胆管炎(PBC)及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒(RSV)的ASC10、用于人类免疫缺陷病毒(HIV)功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。
发行价格:
14.000
{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":6.67,"timestamp":1746691696014,"preClose":6.33,"halted":0,"volume":3316000,"delay":0,"floatShares":964000000,"shares":964000000,"eps":-0.3225623804572513,"marketStatus":"已收盘","change":0.34,"latestTime":"05-08 16:08:16","open":6.33,"high":6.74,"low":6.33,"amount":21813915,"amplitude":0.064771,"askPrice":6.67,"askSize":16000,"bidPrice":6.63,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":-0.3225623804572513,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746754200000},"marketStatusCode":5,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":6.33,"openAndCloseTimeList":[[1746667800000,1746676800000],[1746680400000,1746691200000]],"volumeRatio":1.348495,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672","defaultTab":"news","newsList":[{"id":"2533929301","title":"歌礼制药-B:股价涨 3.32% 减肥药催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2533929301","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533929301?lang=zh_cn&edition=full","pubTime":"2025-05-08 12:42","pubTimestamp":1746679365,"startTime":"0","endTime":"0","summary":"歌礼制药近日称将在西班牙马拉加举行的第 32 届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物 ASC47 的早期研究。此外,有传闻称“世卫组织计划首次将减肥药纳入基本药物目录以治疗成人肥胖症”。5 月 7 日,世卫组织正式回应,治疗成年肥胖患者的指南正按程序全面制定,预计 2025 年 8 月或 9 月出台最终方案。中信证券此前指,预计后续相关事件将对减肥药板块形成反复催化,有望形成跨年度的主题行情。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081441239752da30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081441239752da30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01672","BK1191","01477","BK1574","BK1161"],"gpt_icon":0},{"id":"2533294914","title":"歌礼制药-B股价上涨超3% 将公布肥胖症药物早期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533294914","media":"DoNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533294914?lang=zh_cn&edition=full","pubTime":"2025-05-08 12:06","pubTimestamp":1746677162,"startTime":"0","endTime":"0","summary":"5月8日,歌礼制药-B(01672)午前股价上涨3.32%,报6.54港元。公司将在西班牙马拉加举行的第32届欧洲肥胖症大会上报告肥胖症候选药物ASC47的早期研究结果。ASC47为歌礼自主研发的小分子激动剂,已获FDA批准与司美格鲁肽联用治疗肥胖症。此外,世卫组织计划制定成年肥胖患者治疗指南,预计2025年8月或9月出台。业内人士分析,减肥药板块有望形成跨年度主题行情。免责声明:本文内容由开放的智能模型自动生成,仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050812081994f00378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050812081994f00378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","01477","01672","BK1574","BK1191"],"gpt_icon":0},{"id":"2533943501","title":"港股异动 | 歌礼制药-B(01672)涨超3% 将公布肥胖症候选药物ASC47早期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533943501","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533943501?lang=zh_cn&edition=full","pubTime":"2025-05-08 11:30","pubTimestamp":1746675049,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,歌礼制药-B涨超3%,截至发稿,涨3.48%,报6.55港元,成交额743.52万港元。消息面上,歌礼制药近日宣布将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。美国食品药品监督管理局已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。此外,有传闻称“世卫组织计划首次将减肥药纳入基本药物目录以治疗成人肥胖症”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01477","01672","BK1161","BK1191","BK1515"],"gpt_icon":0},{"id":"2533622312","title":"港股概念追踪|传闻世卫组织计划将减肥药纳入基本目录 减肥药研发进展加速(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533622312","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533622312?lang=zh_cn&edition=full","pubTime":"2025-05-07 15:04","pubTimestamp":1746601499,"startTime":"0","endTime":"0","summary":"有传闻称“世卫组织计划首次将减肥药纳入基本药物目录以治疗成人肥胖症”。对此,世界卫生组织独家回应《人民财讯》称,自2022年以来,世卫组织一直在针对不同年龄组制定一套关于肥胖预防、护理和治疗的新指南。另外,上述药物目前正由世界卫生组织基本药物选择与使用专家委员会进行评审。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0634319403.HKD","01672","LU0700851271.USD","LU0143863784.USD","LU1023057109.AUD","LU0359201612.USD","LU2476274720.SGD","LU0823413587.USD","BK1521","LU0918141887.USD","LU0039217434.USD","BK1607","BK1574","YANG","LU1770036033.HKD","LU0348816934.USD","LU0348827113.USD","HSTECH","LU2476274308.USD","LU0588546209.SGD","LU2087589342.USD","LU1961090484.USD","LU2778985437.USD","LU2097828474.EUR","HSCEI","LU0531971595.HKD","SG9999002463.SGD","LU0871576103.HKD","BK1502","LU0052750758.USD","LU1328277881.USD","HXXD.SI","LU0611395673.USD","LU0327786744.USD","LU0561508036.HKD","LU2097828631.EUR","LU1481107354.HKD","LU2039709279.SGD","LU1868837565.USD","LU0345775950.USD","81810","LU1868838027.USD","BK1618","LU0456827905.SGD","BK1193","BK1575","LU0572944931.SGD"],"gpt_icon":1},{"id":"2533625702","title":"歌礼制药-B盘中异动 下午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533625702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533625702?lang=zh_cn&edition=full","pubTime":"2025-05-07 13:54","pubTimestamp":1746597287,"startTime":"0","endTime":"0","summary":"2025年05月07日下午盘13时54分,歌礼制药-B股票出现异动,股价大幅下跌5.02%。截至发稿,该股报6.250港元/股,成交量132万股,换手率0.14%,振幅8.36%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。歌礼制药-B股票所在的生物技术行业中,整体跌幅为4.43%。歌礼制药-B公司简介:歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507135447a474e995&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507135447a474e995&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","BK1515","01477","BK1161","BK1191"],"gpt_icon":0},{"id":"2533613097","title":"金十数据整理:每日港股市场要闻速递(5月7日 周三)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533613097","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533613097?lang=zh_cn&edition=full","pubTime":"2025-05-07 09:12","pubTimestamp":1746580378,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4505","BK4099","09868","EVS.SI","XPEV","BK4526","BK1157","BK1594","07226","BK4551","BK1588","BK1555","01477","LU0997586861.USD","BK1554","YANG","LU0593848301.USD","BK1575","HSTECH","BK1574","00512","BK1154","BK1191","01250","06158","BK4144","BK1161","BK1119","BK4555","01672","BK1610","HSCEI","BK4614","BK1240","ECO","00182","BK1558","BK1539","BK1587","01332","BK1515"],"gpt_icon":1},{"id":"2533910476","title":"智通港股早知道 | 央行等部门将介绍一揽子金融政策支持稳市场稳预期 港交所推出“科企专线”","url":"https://stock-news.laohu8.com/highlight/detail?id=2533910476","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533910476?lang=zh_cn&edition=full","pubTime":"2025-05-07 07:18","pubTimestamp":1746573511,"startTime":"0","endTime":"0","summary":"央行等部门将介绍一揽子金融政策支持稳市场稳预期国务院新闻办公室将于5月7日上午9时举行新闻发布会,请中国人民银行、国家金融监督管理总局、中国证券监督管理委员会负责人介绍“一揽子金融政策支持稳市场稳预期”有关情况,并答记者问。欧盟周二表示,特朗普正在进行的贸易调查将使欧盟面临关税的商品数额增加到5490亿欧元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"17880f2c2ca17d5d1327fe3b361a8f90","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["YANG","BK1183","BK1574","HSTECH","159940","BK4614","HSCEI","BK1515","01672","00512","BK1191","02432","BK1161"],"gpt_icon":1},{"id":"2533730570","title":"歌礼宣布将在第32届欧洲肥胖症大会以口头和壁报形式报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533730570","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533730570?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:55","pubTimestamp":1746521700,"startTime":"0","endTime":"0","summary":"香港 2025年5月6日 /美通社/ -- 歌礼制药有限公司今日宣布将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。口头报告细节 标题:脂肪靶向、减重不减肌的肥胖症候选药物ASC47在DIO小鼠中显示出显著的减重效果,且不减肌 摘要类别 / 主题:肥胖症管理和干预新兴疗法 摘要编号:0254 会议:T1摘要报告环节:新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4680668_ZH80668_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1161","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2533749915","title":"歌礼制药(01672)将在第32届欧洲肥胖症大会上报告ASC47早期研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533749915","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533749915?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:51","pubTimestamp":1746521494,"startTime":"0","endTime":"0","summary":"金吾财讯 | 歌礼制药 宣布,将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。ASC47是一款由歌礼自主研发的、脂肪靶向、超长效皮下注射的甲状腺激素受体β选择性小分子激动剂。ASC47具有独特的差异化特性,能够靶向脂肪,从而在脂肪组织中产生剂量依赖性的高药物浓度。美国食品药品监督管理局已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958181","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","BK1515","01672","01477","BK1574"],"gpt_icon":0},{"id":"2533579335","title":"歌礼制药:欧洲肥胖症大会报告ASC47研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533579335","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533579335?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:43","pubTimestamp":1746520990,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1515","BK1141","01672","01477","BK1191","BK1574","03347","BK1576","BK1583","BK1161"],"gpt_icon":0},{"id":"2533798085","title":"歌礼制药-B(01672)将在第32届欧洲肥胖症大会报告脂肪靶向、减重不减肌肥胖症候选药物ASC47研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2533798085","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533798085?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:42","pubTimestamp":1746520946,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B 公布,将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。ASC47是一款由歌礼自主研发的、脂肪靶向、超长效皮下注射的甲状腺激素受体β选择性小分子激动剂。ASC47具有独特的差异化特性,能够靶向脂肪,从而在脂肪组织中产生剂量依赖性的高药物浓度。美国食品药品监督管理局已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1191","BK1161","BK1515","01477","01672"],"gpt_icon":0},{"id":"2533510994","title":"歌礼制药-B盘中异动 快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533510994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533510994?lang=zh_cn&edition=full","pubTime":"2025-05-06 10:10","pubTimestamp":1746497428,"startTime":"0","endTime":"0","summary":"2025年05月06日早盘10时10分,歌礼制药-B股票出现波动,股价快速上涨5.04%。截至发稿,该股报6.880港元/股,成交量98.9万股,换手率0.10%,振幅5.80%。歌礼制药-B股票所在的生物技术行业中,整体跌幅为0.84%。其相关个股中,科济药业-B、歌礼制药-B、科笛-B涨幅较大,振幅较大的相关个股有百奥赛图-B、诺诚健华、科济药业-B,振幅分别为11.08%、9.20%、7.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050610102894ed683f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050610102894ed683f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01477","BK1574","BK1191","01672"],"gpt_icon":0},{"id":"2531038672","title":"歌礼制药-B(01672)因购股权获行使合计发行4.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531038672","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531038672?lang=zh_cn&edition=full","pubTime":"2025-04-30 19:06","pubTimestamp":1746011194,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,由于合资格参与者根据本公司于2019年6月6日采纳的购股权计划行使购股权,本公司于2025年4月30日发行1.8万股普通股。由于合资格参与者根据本公司于2019年6月6日采纳的购股权计划行使购股权,本公司于2025年4月30日发行2.2万股普通股。由于合资格参与者根据本公司于2019年6月6日采纳的购股权计划行使购股权,本公司于2025年4月30日发行7000股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01672","BK1161","BK1515","01477","BK1574"],"gpt_icon":0},{"id":"2531503315","title":"歌礼制药-B04月30日主力净流出28.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531503315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531503315?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000922,"startTime":"0","endTime":"0","summary":"04月30日, 歌礼制药-B股价跌4.94%,报收6.35元,成交金额1092.6万元,换手率0.18%,振幅8.08%,量比0.32。歌礼制药-B今日主力资金净流出28.5万元,上一交易日主力净流入202.3万元。该股近5个交易日下跌1.87%,主力资金累计净流入15.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1629.1万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170430a6ce989f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170430a6ce989f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01672","BK1191","BK1574","BK1515","01477"],"gpt_icon":0},{"id":"2531170997","title":"【港股收评:恒生指数涨0.51%,恒生科技指数涨1.35%】港股收盘,恒生指数涨0.51%,恒生科技指数涨1.35%。港股科技ETF(159751)收盘上涨1.44%,恒生港股通ETF(159318)收盘上涨0.58%。美图公司涨超10%,周大福涨超8%。老铺黄金跌超5%,歌礼制药-B跌超4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531170997","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531170997?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:09","pubTimestamp":1746000575,"startTime":"0","endTime":"0","summary":"港股收盘,恒生指数涨0.51%,恒生科技指数涨1.35%。港股科技ETF(159751)收盘上涨1.44%,恒生港股通ETF(159318)收盘上涨0.58%。美图公司涨超10%,周大福涨超8%。老铺黄金跌超5%,歌礼制药-B跌超4%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30160950042174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MCHmain","BK1227","BK1095","BK1613","HSCEI","BK1602","01672","513990","159318","BK1544","BK1191","BK1612","02833","159751","LU2125910500.SGD","BK1574","YANG","BK1545","IE00BYQNZ168.SGD","BK1161","513020","513600","BK4614","BK1601","BK1224","BK1618","HHImain","SG9999011746.SGD","BK1515","IE00B12V2V27.USD","01477","HSTECH","LU2045819591.USD","01357","BK1609","IE00BYTNYN87.SGD","HSI","BK1502","01929"],"gpt_icon":0},{"id":"2531786386","title":"歌礼制药-B(01672)4月29日根据获采纳购股权计划发行合共18.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531786386","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531786386?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:58","pubTimestamp":1745924305,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,于2025年4月29日根据获采纳购股权计划发行合共18.75万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","01672","BK1191","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2531228017","title":"歌礼制药-B盘中异动 下午盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531228017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531228017?lang=zh_cn&edition=full","pubTime":"2025-04-29 13:46","pubTimestamp":1745905560,"startTime":"0","endTime":"0","summary":"2025年04月29日下午盘13时46分,歌礼制药-B股票出现波动,股价大幅拉升5.02%。截至发稿,该股报6.490港元/股,成交量126.498万股,换手率0.13%,振幅6.31%。资金方面,该股资金流入460.947万港元,流出257.256万港元。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。歌礼制药-B股票所在的生物技术行业中,整体涨幅为2.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429134600a6ccb8a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429134600a6ccb8a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","BK1191","01477","BK1574","01672"],"gpt_icon":0},{"id":"2531230898","title":"歌礼制药-B根据购股权计划发行17.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531230898","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531230898?lang=zh_cn&edition=full","pubTime":"2025-04-29 00:17","pubTimestamp":1745857020,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672)发布公告,由于合资格参与者根据公司于2019年6月6日采...歌礼制药-B(01672)发布公告,由于合资格参与者根据公司于2019年6月6日采纳的购股权计划行使购股权,公司于2025年4月28日发行17.2万股普通股。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042900201294e61f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042900201294e61f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","BK1161","01477","BK1191","BK1515"],"gpt_icon":0},{"id":"2530285626","title":"歌礼制药-B(01672)根据购股权计划发行17.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530285626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530285626?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:33","pubTimestamp":1745847187,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,由于合资格参与者根据公司于2019年6月6日采纳的购股权计划行使购股权,公司于2025年4月28日发行17.2万股普通股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1161","BK1191","BK1574","BK1515","01477"],"gpt_icon":0},{"id":"2530441476","title":"加入GLP-1混战,“中国本土丙肝药一哥”换赛道,歌礼制药欲靠减肥药翻身","url":"https://stock-news.laohu8.com/highlight/detail?id=2530441476","media":"时代财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530441476?lang=zh_cn&edition=full","pubTime":"2025-04-28 15:01","pubTimestamp":1745823691,"startTime":"0","endTime":"0","summary":"昔日被业界称为“中国本土丙肝一哥”的歌礼制药(01672.HK),如今官网上已经鲜少有丙肝产品的身影。GLP-1类药物取而代之,在官网管线中排位靠前,官方微信公众号亦频繁披露GLP-1减重产品相关数据。这似乎预示着,这家以丙肝药物起家的药企正意欲借助GLP-1药物打一场翻身战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504283391113086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4590","BK1574","GLP","BK4144","01672","BK1191","01477","BK1515","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":-0.0031},{"period":"1month","weight":0.2788},{"period":"3month","weight":0.5746},{"period":"6month","weight":3.0839},{"period":"1year","weight":3.5214},{"period":"ytd","weight":1.103}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":0.1444},{"period":"3month","weight":0.0862},{"period":"6month","weight":0.0947},{"period":"1year","weight":0.228},{"period":"ytd","weight":0.1312}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎(NASH)或原发性胆汁性胆管炎(PBC)及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒(RSV)的ASC10、用于人类免疫缺陷病毒(HIV)功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.137639},{"month":2,"riseRate":0.714286,"avgChangeRate":0.094063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.058802},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.059274},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.022534},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058787},{"month":7,"riseRate":0.5,"avgChangeRate":0.006985},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090298},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.044648},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.021896},{"month":11,"riseRate":0.857143,"avgChangeRate":0.138187},{"month":12,"riseRate":0.571429,"avgChangeRate":0.13144}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}